Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Candemore vs Atacand in Hypertension with Congestive Heart Failure
NCT01682564Phase 4Completed
- Sponsor
- Chong Kun Dang Holdings
- Start
- Jan 2012
- Primary completion
- Oct 2014
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of candesartan cilexetil in hypertension (HTN), heart failure (HF), sponsored by Chong Kun Dang Holdings. Started Jan 2012; status: completed.
02
Drugs
candesartan cilexetil
03
Conditions
hypertension (HTN)heart failure (HF)
Beyond the preview
Go deeper on NCT01682564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01682564.